Nektar Therapeutics(CH:NKTR)
CH:NKTR
Nektar Therapeutics earnings date
Nektar Therapeutics (NKTR) Q2 2025 Earnings Report
1 Followers
CH:NKTR Q2 2025 EPS Results
- Actual EPS
- -CHF 2.48
- Consensus EPS
- -CHF 2.55
- Beat/Miss
- Beat by +CHF 0.07
- One Year Ago EPS
- -CHF 3.15
CH:NKTR Q2 2025 Revenue Results
- Actual Revenue
- CHF 9.40M
- Expected Revenue
- CHF 7.98M
- Beat/Miss
- Beat by +CHF 1.42M
- YoY Revenue Growth
- -52.42%
Earnings Announcement Details
- Quarter
- Q2 2025
- Date
- 08/07/2025
- Time
- After Close
- Conference Call
- Thursday, August 7, 2025
CH:NKTR Upcoming Earnings
Nektar Therapeutics's next earnings date is estimated for March 2, 2027, based on past reporting schedules.
Q2 2025 Earnings Call Audio
CH:NKTR Q2 2025 Earnings Call
0:00 / 0:00
Q2 2025 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2025 Earnings Call Summary
No earnings call summary is available for this earnings event.
CH:NKTR Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 02, 2027 | 2026 (Q4) | -2.07- | -1.5 | ― | ― |
| Nov 12, 2026 | 2026 (Q3) | -1.74-1.37 | -1.57 | 12.83% (+0.20) | |
| Aug 13, 2026 | 2026 (Q2) | -1.66-1.03 | -2.48 | 58.31% (+1.45) | |
| May 07, 2026 | 2026 (Q1) | -1.33-1.53 | -3.03 | 49.44% (+1.50) | |
| Mar 12, 2026 | 2025 (Q4) | -2.08-1.50 | 0.38 | -495.56% (-1.87) | |
| Nov 06, 2025 | 2025 (Q3) | -2.26-1.57 | -2.27 | 30.74% (+0.70) | |
| Aug 07, 2025 | 2025 (Q2) | -2.55-2.48 | -3.15 | 21.33% (+0.67) | |
| May 08, 2025 | 2025 (Q1) | -2.16-3.03 | -2.4 | -26.32% (-0.63) | |
| Mar 12, 2025 | 2024 (Q4) | -1.710.38 | -2.77 | 113.64% (+3.15) | |
| Nov 07, 2024 | 2024 (Q3) | -2.51-2.27 | -3.03 | 25.00% (+0.76) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

